Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07569497
Physical Activity Maintenance Intervention for People With StrokeNorthern Ireland Chest Heart and StrokeActive Not RecruitingNot Applicable
NCT07569497Active Not Recruiting
Not Applicable
Physical Activity Maintenance Intervention for People With StrokeNorthern Ireland Chest He...
NCT07568639
Multi-Site Cortical Puncture for DORFirst Affiliated Hospital of Guangxi Medical UniversityNot Yet RecruitingNot Applicable
NCT07568639Not Yet Recruiting
Not Applicable
Multi-Site Cortical Puncture for DORFirst Affiliated Hospital...
NCT07570914
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver MetastasesTianjin Medical University Cancer Institute and HospitalNot Yet RecruitingPhase 2
NCT07570914Not Yet Recruiting
Phase 2
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitab...Tianjin Medical Universit...
NCT07570576
Front-of-package Warning Labels for Sugar Content in Sugar-sweetened BeveragesChinese University of Hong KongNot Yet RecruitingNot Applicable
NCT07570576Not Yet Recruiting
Not Applicable
Front-of-package Warning Labels for Sugar Content in Sugar-sweetened BeveragesChinese University of Hon...
NCT07569081
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) SyndromeGlaxoSmithKlineNot Yet RecruitingPhase 2
NCT07569081Not Yet Recruiting
Phase 2
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With V...GlaxoSmithKline
NCT07568613
Comparing PSMA PET/CT and MRI-RSI for Finding and Outlining Tumors Inside the Prostate in Men With Newly Diagnosed Prostate CancerGerman Oncology Center, CyprusRecruitingNot Applicable
NCT07568613Recruiting
Not Applicable
Comparing PSMA PET/CT and MRI-RSI for Finding and Outlining Tumors Inside the Pr...German Oncology Center, C...
NCT07569848
Outcomes of Surgical Treatment Using a Custom-made Device for Total Ankle and Talar Replacement in the Management of Severe Cases of Bone Loss or Bone Compromise: a Pilot Study.Istituto Ortopedico RizzoliRecruiting
NCT07569848Recruiting
—
Outcomes of Surgical Treatment Using a Custom-made Device for Total Ankle and Ta...Istituto Ortopedico Rizzo...
NCT07570797
Mentor-Supported Digital Literacy TrainingErzincan Binali Yildirim UniversitesiNot Yet RecruitingNot Applicable
NCT07570797Not Yet Recruiting
Not Applicable
Mentor-Supported Digital Literacy TrainingErzincan Binali Yildirim...
NCT07571681
Colchicine for Autoimmune and Subacute ThyroiditisMansoura UniversityNot Yet RecruitingPhase 2
NCT07571681Not Yet Recruiting
Phase 2
Colchicine for Autoimmune and Subacute ThyroiditisMansoura University
NCT07570498
Strengthening the Parent-Child Relationship Through Urban NatureThe Chinese University of Hong Kong, ShenzhenCompletedNot Applicable
NCT07570498Completed
Not Applicable
Strengthening the Parent-Child Relationship Through Urban NatureThe Chinese University of...
NCT07571902
Revised-Paravertebral Nerve Blocks for Enhanced Recovery After Stoma ClosureSixth Affiliated Hospital, Sun Yat-sen UniversityNot Yet RecruitingNot Applicable
NCT07571902Not Yet Recruiting
Not Applicable
Revised-Paravertebral Nerve Blocks for Enhanced Recovery After Stoma ClosureSixth Affiliated Hospital...
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07570368
Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to Enhance Neoadjuvant Chemotherapy Response in Locally Advanced Breast CancerUniversitas AirlanggaNot Yet RecruitingNot Applicable
NCT07570368Not Yet Recruiting
Not Applicable
Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to E...Universitas Airlangga
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07570147
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and Injections in Healthy Adult ParticipantsAbbVieNot Yet RecruitingPhase 1
NCT07570147Not Yet Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Asc...AbbVie
NCT07571057
Effects of an 8-week Jump Squat 15-m Swimming Start SwimmersFederal University of VicosaActive Not RecruitingNot Applicable
NCT07571057Active Not Recruiting
Not Applicable
Effects of an 8-week Jump Squat 15-m Swimming Start SwimmersFederal University of Vic...
NCT07569770
Comparing High-Protein and Low-Protein Multi-Ingredient Supplements for Body Composition and Performance in Elite Rugby PlayersUniversity of TaipeiCompletedNot Applicable
NCT07569770Completed
Not Applicable
Comparing High-Protein and Low-Protein Multi-Ingredient Supplements for Body Com...University of Taipei
NCT07570082
Drug-Drug Interaction Study of Atumelnant in Healthy ParticipantsCrinetics Pharmaceuticals Inc.RecruitingPhase 1
NCT07570082Recruiting
Phase 1
Drug-Drug Interaction Study of Atumelnant in Healthy ParticipantsCrinetics Pharmaceuticals...
NCT07568717
Healing Together: Partners' Experiences in the Journey of Sexual Trauma Recovery Through the Intervention Take Your Sexuality Back for Sexually Traumatized Women.NTNU Health (sponsor)Active Not RecruitingNot Applicable
NCT07568717Active Not Recruiting
Not Applicable
Healing Together: Partners' Experiences in the Journey of Sexual Trauma Recovery...NTNU Health (sponsor)
Result Breakdown
Not yet recruiting10 (50%)
Recruiting5 (25%)
Active, not recruiting3 (15%)
Completed2 (10%)
not_applicable12 (60%)
Phase 25 (25%)
Phase 12 (10%)
Not Specified1 (5%)